课题基金 / 基金详情

Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression

Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression
白藜芦醇、碳水化合物限制与前列腺癌进展
批准号：
8310811
负责人：
Stephen Jay Freedland
金额：
$30.05万
依托单位：
DUKE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-09-15 至 2014-07-31
来源：
https://reporter.nih.gov/project-details/8310811
关键词：
AccountingAndrogensAnimalsApoptosisBody WeightCarbohydratesCaringCessation of lifeClinical ResearchClinical TrialsComplementary MedicineDataDevelopmentDietDiet ModificationDietary FatsDoseEpidemiologyFat-Restricted DietFatty acid glycerol estersFoundationsFutureGoalsGrowthHealthHumanHyperphagiaIn VitroInsulinInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IIntakeMacronutrients NutritionMalignant NeoplasmsMalignant neoplasm of prostateMorbidity - disease rateMusNecrosisPhenotypePhytochemicalProteinsPublic HealthReducing dietRelative (related person)Research DesignResveratrolRoleSignal TransductionSolidSomatomedinsTestingTransgenic MiceTransgenic OrganismsUnited StatesWeightWeight GainWorkXenograft procedureandrogen independent prostate cancerbasecancer cellcancer therapycancer typefeedingimprovedin vivomenmortalitynovelpre-clinicalpreclinical studypreventtumortumor progression

项目摘要

项目成果

Stephen Jay Freedland的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PUBLIC HEALTH STATEMENT Prostate cancer is a major cause of morbidity and mortality among men in the United States. In this proposal, we aim to develop novel non-toxic complementary treatments aimed at slowing prostate cancer progression: dietary modification and phytopharmaceuticals. If these pre-clinical studies are successful, this will lay a solid foundation for future clinical studies among men with prostate cancer, which eventually stand the possibility of radically altering and improving care for men with prostate cancer.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy.
DOI： 10.1158/1055-9965.epi-14-0236
发表时间： 2014-11
期刊： Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子： --
作者： [Allott EH, Howard LE, Song HJ, Sourbeer KN, Koontz BF, Salama JK, Freedland SJ]
通讯作者： Freedland SJ
Autoantibodies against cell surface GRP78 promote tumor growth in a murine model of melanoma.
DOI： 10.1097/cmr.0b013e3283426805
发表时间： 2011-02
期刊： Melanoma research
影响因子： 2.2
作者： [de Ridder GG, Gonzalez-Gronow M, Ray R, Pizzo SV]
通讯作者： Pizzo SV
Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
DOI： 10.1111/bju.12720
发表时间： 2014-11
期刊： BJU international
影响因子： 4.5
作者： [Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ]
通讯作者： Freedland SJ
Low-Carbohydrate Diets and Prostate Cancer: How Low Is "Low Enough"?
DOI： 10.1158/1940-6207.capr-10-0071
发表时间： 2010-09-01
期刊： CANCER PREVENTION RESEARCH
影响因子： 3.3
作者： [Masko, Elizabeth M., Thomas, Jean A., II, Freedland, Stephen J.]
通讯作者： Freedland, Stephen J.
共 13 条
    A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment
    • 批准号：
      10568656
    • 项目类别：
    • 资助金额：
      $73.91万
    • 财政年份：
      2023
    • 负责人：
      Stephen Jay Freedland
    • 依托单位：
      CEDARS-SINAI MEDICAL CENTER
    KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology
    Racial Differences in Prostate Cancer Molecular Subtyping
    • 批准号：
      10381279
    • 项目类别：
    • 资助金额：
      $8.5万
    • 财政年份：
      2021
    • 负责人：
      Stephen Jay Freedland
    • 依托单位：
      CEDARS-SINAI MEDICAL CENTER
    Racial Differences in Prostate Cancer Molecular Subtyping
    • 批准号：
      9889065
    • 项目类别：
    • 资助金额：
      $55.03万
    • 财政年份：
      2018
    • 负责人：
      Stephen Jay Freedland
    • 依托单位：
      CEDARS-SINAI MEDICAL CENTER
    海外基金